Prevalence and Regional Differences of Diabetic Retinopathy in Sub-Saharan Africa: Insights from a Systematic Review and Meta-Analysis

• by Mohamed Farah Ismail, Intisar Khalafalla, Zakaria Omar Sheck, Sowda Abdikariim Shiekh Isse, Fathi Abdi Farah, Ibrahim Abdirahman Mohamed, Abdulkarim Ismail Qarbote, Abdikarim Ahmed Warsame, Naima Abdinour Salah, Amina Mohamed Mire, Bahja Ahmed Mumin

• December 26, 2025

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

• by Kerri Miller

• March 11, 2026

• 5 min

Retina Biomarkers for Treatment Selection in DME

• by Kailynn M. Barton, BS, Muhammad Abidi, BS, Rajiv M. Sastry, BA, John B. Miller, MD

• May 1, 2026

• 14 min

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

• by Matthew Solan

• April 23, 2026

• 4 min